Cargando…
Designer proteins that competitively inhibit Gα(q) by targeting its effector site
During signal transduction, the G protein, Gα(q), binds and activates phospholipase C-β isozymes. Several diseases have been shown to manifest upon constitutively activating mutation of Gα(q), such as uveal melanoma. Therefore, methods are needed to directly inhibit Gα(q). Previously, we demonstrate...
Autores principales: | Hussain, Mahmud, Cummins, Matthew C., Endo-Streeter, Stuart, Sondek, John, Kuhlman, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633581/ https://www.ncbi.nlm.nih.gov/pubmed/34715131 http://dx.doi.org/10.1016/j.jbc.2021.101348 |
Ejemplares similares
-
De novo design of stable proteins that efficaciously inhibit oncogenic G proteins
por: Cummins, Matthew C., et al.
Publicado: (2023) -
The Salmonella Typhimurium effector SteC inhibits Cdc42-mediated signaling through binding to the exchange factor Cdc24 in Saccharomyces cerevisiae
por: Fernandez-Piñar, Pablo, et al.
Publicado: (2012) -
Signaling efficiency of Gαq through its effectors p63RhoGEF and GEFT depends on their subcellular location
por: Goedhart, Joachim, et al.
Publicado: (2013) -
Type III Effector Activation via Nucleotide Binding, Phosphorylation, and Host Target Interaction
por: Desveaux, Darrell, et al.
Publicado: (2007) -
Correction: Type III Effector Activation via Nucleotide Binding, Phosphorylation, and Host Target Interaction
por: Desveaux, Darrell, et al.
Publicado: (2007)